Answer
Systemic corticosteroids and other immunosuppressants should be avoided before starting nivolumab because they may interfere with its pharmacodynamic activity; however, they can be used afterward for immune-related adverse reactions, and preliminary results suggest that immunosuppression after treatment starts does not preclude a nivolumab response.
Sources for this answer
- OPDIVO 10 mg/mL concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 70Document updated
Sources checked